CBO and JCT have estimated the effects on revenues and spending of many of the President’s budgetary proposals. This report builds on an earlier one that focused on the President’s proposals for discretionary spending.
CBO and JCT have estimated the effects on revenues and spending of many of the President’s budgetary proposals. This report builds on an earlier one that focused on the President’s proposals for discretionary spending.
CBO discusses prescription drug prices and approaches aimed at reducing those prices. Some of the approaches would cap prices or limit their growth, and other approaches would promote price competition or affect the flow of information.
